Congress will be in session this week for Committee and floor business.
The No Surprises Act’s RxDC reporting deadline is this Tuesday, January 31, for the 2020 and 2021 reporting years. RxBenefits informs us, “Optum, Caremark, and Express Scripts have finalized their submission files and confirmed that all submissions would be completed before January 31, 2023, if not already filed.”
From the public health front —
- NPR Shots explains why your kids are germ vectors, albeit adorable ones.
- Fortune Wells reports that “Researchers at the Institute of Psychiatry, Psychology & Neuroscience at King’s College London have developed a blood-based test that can detect Alzheimer’s disease up to 3.5 years before a clinical diagnosis.” This test would help people decide whether they need the new Biogen/Eisai drug assuming Medicare approves it.
- Fortune Well also points out how employers can reduce workplace stress.
- Kaiser Family Foundation provides us with recent upbeat data on long Covid.